Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells

Research output: Contribution to journalShort survey

David H.M. Steffin, Helen Heslop

Original languageEnglish (US)
Pages (from-to)900-901
Number of pages2
JournalMolecular Therapy
Volume27
Issue number5
DOIs
StatePublished - May 8 2019

PMID: 31005599

Altmetrics

Cite this

Standard

Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells. / Steffin, David H.M.; Heslop, Helen.

In: Molecular Therapy, Vol. 27, No. 5, 08.05.2019, p. 900-901.

Research output: Contribution to journalShort survey

Harvard

Steffin, DHM & Heslop, H 2019, 'Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells' Molecular Therapy, vol. 27, no. 5, pp. 900-901. https://doi.org/10.1016/j.ymthe.2019.04.007

APA

Steffin, D. H. M., & Heslop, H. (2019). Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells. Molecular Therapy, 27(5), 900-901. https://doi.org/10.1016/j.ymthe.2019.04.007

Vancouver

Steffin DHM, Heslop H. Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells. Molecular Therapy. 2019 May 8;27(5):900-901. https://doi.org/10.1016/j.ymthe.2019.04.007

Author

Steffin, David H.M. ; Heslop, Helen. / Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells. In: Molecular Therapy. 2019 ; Vol. 27, No. 5. pp. 900-901.

BibTeX

@article{d1763d19c5e84f0f9a945c05b80343a6,
title = "Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells",
author = "Steffin, {David H.M.} and Helen Heslop",
year = "2019",
month = "5",
day = "8",
doi = "10.1016/j.ymthe.2019.04.007",
language = "English (US)",
volume = "27",
pages = "900--901",
journal = "Molecular therapy : the journal of the American Society of Gene Therapy",
issn = "1525-0016",
publisher = "Nature Publishing Group",
number = "5",

}

RIS

TY - JOUR

T1 - Epigenetic Inhibition Puts Target Antigen in the Crosshairs of CAR T Cells

AU - Steffin, David H.M.

AU - Heslop, Helen

PY - 2019/5/8

Y1 - 2019/5/8

UR - http://www.scopus.com/inward/record.url?scp=85064323156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85064323156&partnerID=8YFLogxK

U2 - 10.1016/j.ymthe.2019.04.007

DO - 10.1016/j.ymthe.2019.04.007

M3 - Short survey

VL - 27

SP - 900

EP - 901

JO - Molecular therapy : the journal of the American Society of Gene Therapy

T2 - Molecular therapy : the journal of the American Society of Gene Therapy

JF - Molecular therapy : the journal of the American Society of Gene Therapy

SN - 1525-0016

IS - 5

ER -

Similar Experts

Similar Research Outputs Profiled Experts

Similar research outputs

Similar Research Outputs

  1. Kinetics of tumor destruction by chimeric antigen receptor-modified T cells

    Anurathapan, U., Chan, R. C., Hindi, H. F., Mucharla, R., Bajgain, P., Hayes, B. C., Fisher, W. E., Heslop, H. E., Rooney, C. M., Brenner, M. K., Leen, A. M. & Vera, J. F., Jan 1 2014, In : Molecular Therapy. 22, 3, p. 623-633 11 p.

    Research output: Contribution to journalArticle

  2. Histone modifications are associated with 9-tetrahydrocannabinol-mediated alterations in antigenspecific t cell responses

    Yang, X., Hegde, V. L., Rao, R., Zhang, J., Nagarkatti, P. S. & Nagarkatti, M., Jul 4 2014, In : Journal of Biological Chemistry. 289, 27, p. 18707-18718 12 p.

    Research output: Contribution to journalArticle

  3. Improving T-cell therapy for relapsed EBV-negative Hodgkin lymphoma by targeting upregulated MAGE-A4

    Cruz, C. R., Gerdemann, U., Leen, A. M., Shafer, J. A., Ku, S., Tzou, B., Horton, T. M., Sheehan, A., Copeland, A., Younes, A., Rooney, C. M., Heslop, H. & Bollard, C. M., Nov 15 2011, In : Clinical Cancer Research. 17, 22, p. 7058-7066 9 p.

    Research output: Contribution to journalArticle

  4. Adoptive Immunotherapy with Antigen-Specific T Cells Expressing a Native TCR

    Leung, W. & Heslop, H., Apr 1 2019, In : Cancer immunology research. 7, 4, p. 528-533 6 p.

    Research output: Contribution to journalReview article

ID: 47990178